U.S. Markets closed

Pfizer Is the Latest Drug Company to Put Its Credit Rating at Risk With M&A

Alexandra Scaggs

S&P Ratings has put Pfizer on watch for a downgrade after the pharma giant said it plans to acquire a cancer-drug maker.